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Abstract. Molecular techniques based on real-time polymerase chain reaction (qPCR) allow the detection and
quantification of DNA but are unable to distinguish between signals from dead or live cells. Because of the lack of sim-
ple techniques to differentiate between viable and nonviable cells, the aim of this study was to optimize and evaluate a
straightforward test based on propidium monoazide (PMA) dye action combined with a qPCR assay (PMA-qPCR) for
the selective quantification of viable/nonviable epimastigotes of Trypanosoma cruzi. PMA has the ability to penetrate the
plasma membrane of dead cells and covalently cross-link to the DNA during exposure to bright visible light, thereby
inhibiting PCR amplification. Different concentrations of PMA (50–200 μM) and epimastigotes of the Maracay strain
of T. cruzi (1 × 105–10 parasites/mL) were assayed; viable and nonviable parasites were tested and quantified by qPCR
with a TaqMan probe specific for T. cruzi. In the PMA-qPCR assay optimized at 100 μM PMA, a significant qPCR
signal reduction was observed in the nonviable versus viable epimastigotes treated with PMA, with a mean signal
reduction of 2.5 logarithm units and a percentage of signal reduction > 98%, in all concentrations of parasites assayed.
This signal reduction was also observed when PMA-qPCR was applied to a mixture of live/dead parasites, which
allowed the detection of live cells, except when the concentration of live parasites was low (10 parasites/mL). The
PMA-qPCR developed allows differentiation between viable and nonviable epimastigotes of T. cruzi and could thus be
a potential method of parasite viability assessment and quantification.
INTRODUCTION
Trypanosoma cruzi is a parasitic protozoan that causes
Chagas disease in human beings and other mammals, and is
transmitted by triatomine vectors in endemic zones, as well
as by nonvector routes, including vertically from mother to
newborn, organ transplantation, blood transfusion, and other
less common ways such as laboratory accidents. This sys-
temic chronic illness represents the third highest parasitic dis-
ease burden after malaria and schistosomiasis, and is a serious
public health issue in 21 endemic Latin American countries,
with an estimated 8 million people already infected and about
50,000 new cases per year.1–3 With increasing globalization,
Chagas disease is also becoming a health threat worldwide.
Cases arising from blood transfusion, organ transplantation,
and vertical transmission are being increasingly detected in
non-endemic areas, including the United States, Canada,
several European countries, and Oceania, as a consequence
of large-scale migration of infected individuals from Latin
America.4–8 Moreover, oral infection of Chagas disease is
currently considered as an important transmission pathway
in endemic areas, even though where vectorial transmis-
sion has been successfully interrupted,9 with high mortality
rates.4 In the Brazilian Amazon region, several outbreaks
of Chagas disease have been described due to oral transmis-
sion, involving more than 1,500 patients.10 Chagas disease
could therefore be classified as a foodborne infection, princi-
pally associated with the consumption of infected food such
as wild animal meat, homemade juices, and artisan beverages
contaminated with the parasite-infected vector.9,11,12
In an effort to achieve a more sensitive detection of
T. cruzi than provided by conventional parasitological tech-
niques, in the last 20 years, PCR technology has been applied
to identify T. cruzi DNA in blood samples or biopsies from
chagasic patients,13,14 which has opened new possibilities in
diagnosis and follow-up assessment of chemotherapy.15–17
PCR has also proved useful for T. cruzi detection in vector
and reservoir studies.18,19 However, a drawback of the PCR
technique is that it cannot distinguish between DNA signals
from live or dead parasites and consequently a positive result
does not imply pathogen viability. Methods to evaluate
T. cruzi viability based on RNA detection are not routinely
used due to their high handling complexity. Likewise, axenic
culture presents low sensitivity and takes a long time to pro-
vide conclusive results.20,21 Saavedra and others have devel-
oped a hybrid PCR and xenodiagnosis (XD) methodology
to evaluate parasite viability in chronic chagasic patients
and improve the sensitivity of diagnosis by XD, but as stated
before, the classic techniques are time consuming, and require
trained personal and special laboratory conditions, among
other drawbacks.22
Recently developed photochemical dyes can be applied
in combination with PCR to detect viable cells, based on
cell membrane integrity. Ethidium monoazide (EMA) and
propidium monoazide (PMA) have the capacity to bind to
free DNA/RNA, but not protected nucleic acid, as they are
cell membrane impermeable. In the case of damaged or dead
cells, the dyes can pass through the membrane and cova-
lently cross-link to organic molecules, including DNA, under
exposure to bright visible light.23,24 This covalent binding
prevents subsequent amplification of DNA by PCR, thereby
indicating cell nonviability. The efficiency of these techniques
depends on a variety of factors, including the type and con-
centration of the dye, the light source, incubation conditions,
and the microorganism, all of which need to be considered
during optimization.25
EMA-PCR and PMA-PCR assays have been applied
to a wide variety of microorganisms, including bacterial
vegetative cells, bacterial spores, fungi, viruses, and yeast,
*Address correspondence to Roser Fisa, Laboratori de Para-
sitologia, Departament de Microbiologia i Parasitologia Sanitàries,
Facultat de Farmàcia, Universitat de Barcelona, Avinguda Joan
XXIII s/n. E-08028, Barcelona, Spain. E-mail: rfisa@ub.edu
1282
principally in the fields of environment and food.26–31 Lately,
they have also been applied in bacterial studies on clinical
samples, indicating that this method constitutes a potential
alternative to diagnosis by microscopy and culture, as well
as in monitoring early treatment response32,33 or in drug
experimental assays.34,35 However, to date, this methodol-
ogy has had only scant application in parasites, for example,
oocysts of Cryptosporidium, cysts of Giardia duodenalis and
trophozoites and cysts of Acanthamoeba castellani in clini-
cal and environmental samples.29,31,36,37 The aim of this
study was to evaluate if PMA-qPCR assay can differentiate
between live and dead epimastigotes of T. cruzi and thus
have potential application in parasite viability assessment
and quantification.
MATERIALS AND METHODS
Epimastigotes of T. cruzi and inactivation treatment.
Epimastigotes of T. cruzi (Maracay strain) were grown in
liver infusion tryptose medium (LIT) at 28°C until the log-
arithmic growth phase. Twenty milliliters of the culture was
centrifuged at 1,800 × g for 10 minutes; the pellet was
suspended in the same medium and viable parasites were
counted in a Rosenthal hemocytometer chamber with trypan
blue dye. The stock was serially diluted 10-fold from 1 ×
105 to 10 parasites/mL with LIT. Each dilution was equally
divided to make two sets of parasite suspension. One set
of parasites was used for live parasite studies and the other
set was subjected to inactivation by exposure to isopropanol
(final concentration of 70%) for 10 minutes. Isopropanol
was removed by harvesting epimastigotes using centrifuga-
tion at 10,000 × g for 5 minutes before resuspension in LIT.
These assays were performed in duplicate. As a control,
an aliquot of each set of parasites was cultured to ensure
the viability or nonviability of the parasites in LIT for
2 weeks.
PMA treatment. PMA (GenIUL, Barcelona, Spain) was
dissolved in water of molecular biology grade (Sigma-
Aldrich, Saint Louis, MO) to obtain a stock solution of
2,000 μM, which was stored at 4°C in darkness for no longer
than 2 months. All subsequent steps using PMA were per-
formed under minimal light conditions. PMA stock solution
was added at a final concentration of 50, 100, and 200 μM
to a total volume of 300 μL of 1 × 105, 1 × 104, and 1 × 103
parasites/mL, both live and dead, to determine the optimal
final PMA concentration. The resulting suspension was incu-
bated for 30 minutes at room temperature in darkness, mixing
every 10 minutes. Live and dead parasites not treated with
PMAwere used as a control. All the samples (treated and not
treated with PMA) were then photoactivated for 15 minutes
in constant mode using a light-emitting diode (LED) source
that emits light in the blue range of the visible spectra (464–
467 nm, 60 W; Phast Blue PhotoActivation System; GenIUL,
Barcelona, Spain). The assay was performed in duplicate.
DNA extraction. Immediately after the photoactivation,
the samples were pelleted by centrifugation at 13,000 × g for
5 minutes, and the remaining supernatant was discarded to
achieve a final volume of 200 μL. DNA extraction was done
with the High Pure PCR Template Preparation kit (Roche,
Mannheim, Germany) and eluted in 200 μL of elution buffer
(10 mM Tris-HCl, pH 8.5) according to the manufacturer’s
instructions. The concentration of eluted DNAwas measured
in a NanoDrop (ND-1000, ThermoScientific, Wilmington, DE)
and stored at −20°C for qPCR analysis. For the extraction
negative control (ENC), LIT was used without a template.
Real time PCR (qPCR) assay. Five microliters of extracted
DNA was amplified by qPCR in a thermocycler (LightCycler
480, Roche) in duplicate. The primers, probes, and condi-
tions of the technique were as described by Piron and
others17 with some modifications. Briefly, the following were
used: Cruzi 1 and Cruzi 2 primers, and a Cruzi 3 probe,
which was labeled with 6-carboxyfluorescein and a minor
groove binder. The final concentrations in the PCR mixture
were as follows: 1 × LightCycler 480 Probes Master (Roche),
750 nM of each T. cruzi primer and 250 nM of the T. cruzi
probe in 20 μL reaction volume. The amplification was run
in 45 cycles and the annealing temperature was 58°C.
A standard curve was constructed with 1/10 serial dilu-
tions, in elution buffer (10 mM Tris-HCl, pH 8.5), of total
DNA extracted from the Maracay strain from 1 × 105 to
1 parasites/mL. Molecular biology-grade water (Sigma-Aldrich)
and ENC were used as negative controls.
The parasitic load of every sample was calculated using
LightCycler 480 software by the second derivative maximum
method. The limit of detection (LOD) of the technique was
calculated in 2 parasite equivalents/mL.17
Statistical analysis. The data were analyzed with IBM
SPSS Statistics. Comparisons were carried out with a one-
way analysis of variance and post hoc Tukey’s honestly sig-
nificant difference. Differences with P values < 0.05 were
considered statistically significant.
RESULTS
qPCR on T. cruzi epimastigotes. The qPCR standard
curve showed a linearity of 0.9881 between the log concen-
trations of epimastigotes and the Cq value, with a dynamic
range from 1 × 105 to 10 parasites/mL and an efficiency
of 90% (Figure 1). Before the PMA treatment, the serial
10-fold diluted stock from 1 × 105 to 10 parasites/mL of
live and dead T. cruzi epimastigotes were measured by
qPCR in Cq values, and expressed in parasite equivalents/
mL (Figure 2). Values for live and dead parasites were
quite similar at all concentrations, indicating that minimal
quantities of DNA were lost in the washing steps of the
procedure. All the control cultures of the epimastigotes
were positive, except 10 parasites/mL and those treated
with isopropanol.
PMA-qPCR optimization on T. cruzi epimastigotes. The
optimum concentration of PMA that provided the greatest
difference in qPCR values between treated viable and non-
viable parasites was expressed in ΔCq values (Cq PMA-
treated dead parasites − Cq PMA-treated live parasites).
Three concentrations of parasites/mL (1 × 103–1 × 105) and
three concentrations of PMA (50, 100, and 200 μM) were
assayed. The best differentiation between live and dead cells
was achieved by 100 μM in all the parasite concentrations
assayed, and increasing the PMA concentration did not
improve the results (Figure 3).
Treated and nontreated with 100 μM PMA concentrations
of live T. cruzi epimastigotes (1 × 105, 1 × 104, 1 × 103,
1 × 102, 10 parasites/mL) were studied by qPCR and no sig-
nificant signal reduction in PMA-treated versus nontreated
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living cells (P > 0.05) was observed, indicating no significant
effect of PMA on live T. cruzi epimastigotes.
To assess the PMA impact on the reduction of the qPCR
signal of dead versus live parasites, the same concentrations
of dead and live T. cruzi epimastigotes were tested (Table 1).
A higher shift was observed for 1 × 105–1 × 103 parasites/mL
with a ΔCq between 9 and 7.5, which is equivalent to a fall
of 2.5–3.2 log units between the viable and nonviable para-
sites; for 1 × 102 and 10 parasites/mL, a ΔCq of around 2.7–
3.7 was detected, which is equivalent to a fall of 1.8 log units.
A significant (P < 0.002) PMA-qPCR signal reduction was
observed for all parasite concentrations studied, except for
10 parasites/mL. The percentage of signal reduction was
between 98.4% and 99.9% for all concentrations studied.
Despite the high level of reduction, a number of parasites were
still detected. The concentration of dead parasites dropped
below 1 parasite equivalent/mL in concentrations ≤ 103
parasites/mL, but at higher parasite concentrations, the
reduction exceeded the LOD of the technique (Figure 4).
Quantification of live T. cruzi from live/dead parasite
mixtures. To observe the effect of a mixture of live and dead
epimastigotes on the qPCR-PMA, a set of 10-fold dilutions
of live parasites ranging from 1 × 105 to 10 parasites/mL was
mixed with a concentration of 1 × 105 dead parasites. This
assay was performed in duplicate, treated and nontreated
with PMA. The qPCR results indicated that the concentra-
tions expressed in parasites equivalent/mL were similar for
all parasite concentrations when untreated (Figure 5). These
results reflect the maximum concentration of dead parasites
in a sample (1 × 105 parasites/mL), and fail to reflect the real
number of live parasites in the mixture. In contrast, the
qPCR values of the PMA-treated mixture indicate a linear
relationship between Cq and the number of viable cells,
which was only affected when the concentration of live cells
FIGURE 1. Standard curve constructed by plotting the mean Cq values, studied in triplicate, with respect to the logarithm10 of the
Trypanosoma cruzi DNA concentrations (10-fold serial dilutions 1 × 105–1 parasite/mL).
FIGURE 2. Results by real time polymerase chain reaction of different concentrations of live and dead parasites before propidium monoazide
treatment (A = 1 × 105; B = 1 × 104; C = 1 × 103; D = 1 × 102; E = 10 parasites/mL). (A) Results expressed in Cq values. (B) Results quantified
in parasite equivalents/mL.
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was low, demonstrating that the concentration results basi-
cally reflect the amount of live parasite DNA in the mixture.
DISCUSSION
Although molecular methods such as PCR can help
to detect and quantify parasites with high sensitivity and
specificity, PCR by itself is unable to differentiate between
live and dead parasites, which can undermine the value of
the results. Recently, qPCR has been tested in combina-
tion with PMA in a variety of microorganisms, principally
those affecting the food industry and more recently in clin-
ical pathogens, to assess treatment effectiveness. In this
study, we assessed the performance of PMA treatment in
minimizing detection signals by qPCR from nonviable epi-
mastigotes of T. cruzi and propose it as a potential tool for
viability quantification.
The photochemical dye PMA at 100 μM significantly
reduced the qPCR signal from nonviable epimastigotes, effec-
tively separating them from viable parasites. The PMA treat-
ment appeared to have no toxic effect on the epimastigotes,
since no significant differences in concentration were observed
between live PMA-treated and nontreated parasites. This
suggests that PMA does not penetrate the membrane of liv-
ing T. cruzi epimastigotes at the tested levels. Similar PMA
concentrations have been used without significant cytotoxic
effects on protozoa such as Cryptosporidium spp. oocysts36
and Mycobacterium tuberculosis bacteria.38
A considerable signal reduction in dead T. cruzi epi-
mastigotes was achieved by PMA-qPCR, with a decrease in
detection of > 98% at all parasite concentrations studied.
Nevertheless, at high parasite concentrations (1 × 105–1 ×
104 parasites/mL), despite the very high signal reduction
(a maximum of 99%), a remaining qPCR signal in the dead
PMA-treated parasites generated a false positive. These
results are consistent with other studies, where PMA was
unable to completely eliminate the qPCR signal of dead
Salmonella serovar Enteritidis, Mycobacterium avium, and
Listeria innocua.39–41 In contrast, in Acanthamoeba spp. (1 ×
106 cysts and trophozoites killed by autoclave), the PMA-
qPCR signal was successfully reduced to zero by enhancing
the PMA concentration to 200 μM, after 100 μM proved
ineffective in differentiating between viable and nonviable
parasites.29 In our study, increasing the PMA concentra-
tion did not further reduce the qPCR signal of dead epi-
mastigotes of T. cruzi. Similarly, Barbau-Piednoir and others
(2014) found that, Cq values for all tested dilutions of dead
bacteria did not differ between 75 and 150 μM of PMA.
To reduce or avoid both false-negative and false-positive
qPCR signals,25 a variety of factors should be taken into
account when optimizing the technique, such as the type
and concentration of dye, the light source, the type of
FIGURE 3. Propidium monoazide (PMA) real-time polymerase chain reaction optimization results, expressed in ΔCq obtained at different
PMA concentrations (50, 100, and 200 μM) when different parasite concentrations were tested (1 × 103–1 × 105 parasites/mL).
TABLE 1
qPCR results of different concentrations of viable and nonviable epimastigotes, treated with 100 μM PMA. Comparison of Cq values, parasite
concentration, and percentage of PMA-qPCR signal reduction
Parasites/mL*
Mean Cq values Mean parasite concentration†
Dead parasites Live parasites ΔCq Dead parasites Live parasites Δ Concentration§ Signal reduction‡ P value
1.00E + 05 24.79 15.82 9.0 3.023E + 02 1.021E + 05 1.018E + 05 99.7 0.001
1.00E + 04 28.12 19.46 8.7 1.165E + 01 9.815E + 03 9.803E + 03 99.8 0.000
1.00E + 03 30.55 23.09 7.5 5.600E − 01 9.575E + 02 9.569E + 02 99.9 0.000
1.00E + 02 30.21 26.48 3.7 8.500E − 01 5.927E + 01 5.842E + 01 98.5 0.002
1.00E + 01 31.76 29.04 2.7 9.000E − 02 5.890E + 00 5.800E + 00 98.4 0.241
PMA = propidium monoazide; qPCR = real-time polymerase chain reaction.
*Concentration of viable and nonviable epimastigotes of Trypanosoma cruzi.
†qPCR results expressed in parasite equivalents/mL.
‡Expressed in percentage.
§Δ Concentration calculated as live parasites − dead parasites.
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microorganism, or the amplicon length. Of the two types of
dye used in this field, PMA is described as more effective in
differentiating between live and dead cells, whereas EMA
is slightly more efficient in signal suppression, although with
the disadvantage that it can penetrate the living cells of some
microorganisms.24,42 The light source, as mentioned above, is
another factor in the generation of false positives. In particu-
lar, studies using halogen lamps without an emission wave-
length specific for PMA show fluctuating efficiency, due to
variable light activation and the intense heat emitted. To
minimize this variability, we used a commercial LED-based
system designed especially for the exposure of cell suspen-
sions to light, with the advantage that LEDs emit light in
the blue range of visible spectra, allowing for optimal dye
FIGURE 4. Propidium monoazide (PMA) real-time polymerase chain reaction results expressed in parasite equivalents/mL of different con-
centrations of live and dead parasites, both treated with PMA. Epimastigotes were studied at A = 1 × 105; B = 1 × 104; C = 1 × 103; D = 1 × 102;
E = 10 parasites/mL. Limit of detection (LOD) = 2 parasite equivalents/mL.
FIGURE 5. Quantification in parasites equivalent/mL of Trypanosoma cruzi from mixture of live (1 × 105–10 parasites/mL) and dead (1 × 105
parasites/mL) parasites, treated and nontreated with 100 μM propidium monoazide.
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activation without heat generation. Therefore, this factor was
ruled out as the cause of the persistent qPCR signal.
Some authors suggest the technique can be further
improved by studying the effect of PCR amplicon length,
an important experimental parameter when analyzing sam-
ples treated with viability dyes.43 Alonso and others (2014)
reported a more effective exclusion of dead cysts of Giardia
duodenalis in a qPCR assay with longer amplicons. Like-
wise, Li and Chen (2013) found a good correlation between
amplicon length and the signal inhibitory effect of PMA
treatment on dead cells of Salmonella spp, concluding that
the best qPCR signal reduction was obtained with the larger
amplicon, albeit with a slight loss of technique efficiency. As
suggested by Soejima and others (2011)44 and Contreras and
other (2011),45 the beneficial effect of targeting longer DNA
sequences is likely due to the increased probability of dye
binding in the targeted region, resulting in a stronger inhibi-
tion of the amplification. The sensitivity of the qPCR assay
is lower when using larger amplicons, which could lead to
false-negative results if the signal falls below the LOD.31,46
Therefore, optimizing a technique involves attaining a bal-
ance between the reduction of the qPCR signal in the dead
cells and sensitivity. In our study, the qPCR technique, previ-
ously validated for diagnosis,17 used a set of primers that
amplify a region of satellite DNA 166 bp long. Therefore, a
larger target gene would probably help to completely elimi-
nate the remaining signal of the dead parasites observed,
although at the risk of reducing the sensitivity of the tech-
nique. Also, some studies suggest that the sequence of the
target gene may influence the noncomplete amplification
signal suppression from dead cells.47,48 Further research on
enhancing the removal of the remaining signal of the dead
parasites is necessary.
Some authors indicate that the ratio between live and
dead cells can affect the performance of the method, consid-
ering that dead cells cannot exceed live cells by a factor
of 1 × 103 without impacting on the PMA-qPCR.25 Other
authors, such as Pan and Breidt, have reported that the lin-
ear relationship between Cq and the number of viable cells
of Listeria monocytogenes was affected when the ratio of
dead cells exceeded 1 × 104 and the concentration of live
cells was less than 1 × 103 CFU/mL.49 Our results showed
that the technique was capable of differentiating live T. cruzi
from a live/dead parasite mixture, despite the high number
of dead cells present in all samples. The technique failed
only when a low concentration of live parasites was com-
bined with a high concentration of dead parasites, which could
be explained by a saturation of PMA by this high number of
dead cells.25
The PMA-qPCR strategy optimized in this study effectively
differentiated between viable and nonviable epimastigotes of
T. cruzi, with a significant reduction in the qPCR signal. This
method has potential application in viability assessment and
quantification due to its various advantages: it requires only
a few hours to carry out, in comparison with an axenic cul-
ture that takes at least 20–30 days; its handling is simple and
straightforward compared with RNA detection techniques;
the use of the highly sensitive and specific TaqMan probe
renders it suitable for application in, for example, raw food
matrices, as it would avoid interference from bacteria or
fungus, a problem in culture techniques. Nevertheless, this
method has its limitations, as the reagents are expensive,
highly trained personnel are required for its application, and
it is not always available in laboratories. It would be desir-
able if the method was tested by other laboratories and on
other trypanosomatids.
The described method could therefore be especially useful
in differentiating DNA from viable parasites in fields such
as food security to prevent oral infections or study out-
breaks, diagnostics to evaluate chemotherapeutic efficacy,
research on vectors and reservoirs, or antitrypanosomal drug
activity assays.
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